Untitled

Abstract

The need for the monitoring of ADRs arise as Clinical Trials focused mainly on the safety and efficacy of the therapeutic substance on the selected population. Many aspects of the drug thus remained unexplored.The process of identifying and preventing ADRs is associated with post marketed drugs i.e., pharmacovigilance, which is extremely important to protect patient health, economic burden associated with ADRs and circulation of large number of over-the-counter and counterfeit drugs in the market. According to the World Health Organisation (WHO), Pharmacovigilance is the science and activity related to the detection, assessment, understanding and prevention of